Relative Bioavailability and Food Effect Study of CVN424

Clinical trial NCT05635461 · COMPLETED

Trial details

NCT number: NCT05635461
Sponsor: Cerevance Beta, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson's Disease

Start date: 2022-10-09
Primary completion: 2022-11-11
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.